期刊名称：JOURNAL OF GASTROINTESTINAL ONCOLOGY ISSN： 2078-6891 出版频率： Bi-monthly 出版社： AME PUBL CO, FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, PEOPLES R CHINA, HONG KONG, 00000   出版社网址： http://www.amegroups.com 期刊网址： http://jgo.amegroups.com 影响因子： 2.892 主题范畴： ONCOLOGY;    GASTROENTEROLOGY & HEPATOLOGY;    China Journals 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Aims and Scope Journal of Gastrointestinal Oncology (Print ISSN 2078-6891; Online ISSN 2219-679X; J Gastrointest Oncol; JGO), the official journal of Society for Gastrointestinal Oncology (SGO), is an open-access, international peer-reviewed journal. It is published quarterly (Sep. 2010- Dec. 2013), bimonthly (Feb. 2014 -) and openly distributed worldwide. JGO publishes manuscripts that focus on updated and practical information about diagnosis, prevention and clinical investigations of gastrointestinal cancer treatment. Specific areas of interest include, but not limited to, multimodality therapy, markers, imaging and tumor biology. JGO is indexed in PubMed, PubMed Central (PMC), Scopus, Science Citation Index Expanded (SCIE) and received its impact factor of 2.536 for the year 2019. Information for Authors JGO is a member of the International Committee of Medical Journal Editors (ICMJE) and follows the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal and the Committee on Publication Ethics (COPE)'s guidelines. Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere. Manuscripts Turnaround Time In-house review: 1-3 weeks External peer review: 1-3 months Publication Ahead of Print: within 1 month after being accepted Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority. Indexing Journal of Gastrointestinal Oncology is indexed and covered by Science Citation Index Expanded (SCIE) PubMed PubMed Central (PMC) Free Medical Journals Google Scholar Index Copernicus WZB database   Instructions to Authors ABOUT THE JOURNAL MANUSCRIPT CATEGORIES 2.1 Original article 2.1.1 Reporting Checklist 2.1.2 Selection and description of participants 2.1.3 Research resource identifiers (RRID) 2.2 Review Article 2.3 Case Report 2.3.1 Reporting Checklist 2.4 Editorial 2.5 Editorial Commentary 2.6 Letter to the Editor 2.7 Study Protocol 2.7.1 Reporting Checklist 2.8 Others MANUSCRIPT SUBMISSION REQUIREMENTS 3.1 Title page 3.2 Abstract and keywords 3.3 Text 3.4 Author contributions 3.5 Data citation 3.6 Acknowledgments 3.7 Footnote 3.7.1 Reporting Checklist 3.7.2 Data Sharing Statement 3.7.3 Peer Review File 3.7.4 Conflicts of Interest 3.7.5 Ethical statement 3.8 References 3.9 Tables 3.10 Figures 3.11 Videos 3.12 Abbreviations and symbols 3.13 Supplementary appendix 3.14 Equations STYLE OF THE MANUSCRIPT   AUTHORSHIP AND CONTRIBUTORSHIP COPYRIGHT AND PERMISSIONS PEER REVIEW PROCESS ARTICLE PROCESSING CHARGES PROOFS OFFPRINTS AND REPRINTS SUBMITTING AND TRACKING MANUSCRIPTS Editorial Board Editor-in-Chief   Gary Yang, MD Loma Linda University Medical Center, Loma Linda, CA. Email: jgoeic@163.com. Dr. Gary Yang is Professor and Dell E. Webb Chair in Radiation Medicine, Loma Linda University in southern California, where he also serves as Residency Program Director and Director of Education and Development. Loma Linda University is the first hospital-based proton treatment center in the United States, providing patients worldwide with cutting-edge proton therapy treatments and access to the world-class doctors and staff. Dr. Yang received his medical degree from Chicago Medical School and completed his internship at Yale University, New Haven, Connecticut, followed by residency training at Emory University, Atlanta, Georgia and fellowship at Johns Hopkins University, Baltimore, Maryland. Before joining Loma Linda University, Dr. Yang was Residency Program Director and Medical Director of Radiation Medicine at Roswell Park Cancer Institute, Buffalo, New York. Dr. Yang is an internationally recognized expert in GI cancers. He is currently the Editor-in-Chief of the Journal of Gastrointestinal Oncology, Associate Editor for the Journal of Thoracic Disease, and editorial board member of the World Journal of GI Oncology and Thoracic Cancer. He is also a reviewer for over 20 peer-reviewed journals and has authored or co-authored more than 150 journal publications, abstracts and book chapters. Dr. Yang was invited as moderator/faculty speaker at various scientific and educational sessions of international conferences including International Society of GI Oncology (ISGIO) and American Society for Radiation Oncology (ASTRO). Research Council of America named Dr. Yang among the "America’s Top Oncologists". He was named to “America's Top Doctors” by Castle Connolly Medical, Ltd. http://jgo.amegroups.com/about/editorialTeam